CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar. 6, 2019--
Therapeutics, Inc. (Nasdaq:AKBA), a biopharmaceutical company
focused on the development and commercialization of therapeutics for
patients with kidney disease, today announced it will host a fourth
quarter and full-year 2018 investor update conference call and webcast
at 4:30 p.m. Eastern Time on Monday, March 18, 2019.
Individuals interested in participating in the call should dial (877)
458-0977 (U.S. and Canada) or (484) 653-6724 (international) using
conference ID number 1376157. To access the webcast, visit the Investors
section of Akebia’s website at www.akebia.com
at least 15 minutes prior to the start of the call to ensure adequate
time for any software downloads that may be required.
Beginning the morning of March 19, 2019, the call will be available for
replay via telephone and the archived webcast will be available on
Akebia’s website. To listen to the telephone replay, dial (855) 859-2056
(U.S. and Canada) or (404) 537-3406 (international) using conference ID
number 1376157. The telephone replay will be available for six days
following the call.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical
company focused on the development and commercialization of therapeutics
for patients with kidney disease. The company was founded in 2007 and is
headquartered in Cambridge, Massachusetts. For more information, please
visit our website at www.akebia.com
which does not form a part of this release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190306005227/en/
Source: Akebia Therapeutics, Inc.
Akebia Therapeutics Contact
Forst / Maghan Meyers